Axogen is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Michael D. Dale, with a market cap of $1.7B.
Common questions about Axogen
Axogen is scheduled to report earnings for Q1 2026 on May 7, 2026. Analysts estimate revenue of $58.1M.
Axogen has approximately 428 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.